AstraZeneca Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Buy" and an average price target of 15,751p. The average 1-year stock price forecast is 28.06% higher than the current stock price, while the lowest is 11,667p (-5.14%) and the highest is 19,816p (+61.11%).

Price Target: 15,751p (+28.06%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	11,667p	15,751p	16,008p	19,816p
Change	-5.14%	+28.06%	+30.14%	+61.11%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	15	15	14	14	14	14
Buy	4	4	4	5	6	6
Hold	3	3	4	3	4	4
Sell	0	0	0	0	0	0
Strong Sell	1	2	2	2	1	1
Total	23	24	24	24	25	25

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emmanuel Papadakis Deutsche Bank	Deutsche Bank	Hold Maintains 11,700p	Hold	Maintains	11,700p	-4.88%	Oct 14, 2026
Unknown Analyst Nordea Markets No rating	Nordea Markets	Buy Upgrades 12,496p → 14,389p	Buy	Upgrades	12,496p → 14,389p	+16.98%	Oct 13, 2026
James Gordon CFA Barclays	Barclays	Buy Maintains 16,000p	Buy	Maintains	16,000p	+30.08%	Oct 13, 2026
Graham Parry Citi	Citi	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Oct 13, 2026
Luisa Hector Berenberg Bank	Berenberg Bank	Buy Maintains 15,000p	Buy	Maintains	15,000p	+21.95%	Oct 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

63.19B

from 58.74B

7.58%

from 58.74B

Revenue Next Year

67.06B

from 63.19B

6.13%

from 63.19B

EPS This Year

10.22

from 9.16

11.58%

from 9.16

EPS Next Year

11.39

from 10.22

11.41%

from 10.22

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	37.42B	44.35B	45.81B	54.07B	58.74B	63.19B
Revenue Growth	40.58%	18.53%	3.29%	18.04%	8.63%	7.58%
Gross Profit	25.41B	35.71B	37.77B	44.44B	47.99B	52.14B
Gross Margin	67.92%	80.52%	82.44%	82.18%	81.71%	82.51%
Operating Income	2.90B	8.81B	9.70B	12.93B	14.29B	21.05B
Net Income	112.00M	3.29B	5.96B	7.04B	10.23B	11.90B
EPS	-	-	-	-	9.16	10.22
EPS Growth	-	-	-	-	11.57%	11.58%
Forward PE	18.61	18.65	17.08	14.36	18.34	15.95
Dividend / Share	2.87	2.90	2.90	3.10	3.20	3.34
Dividend Growth	2.50%	1.05%	-	6.90%	3.23%	4.44%
Free Cash Flow	-	-	-	-	11.77B	9.71B
No. Analysts	-	-	-	-	-	25

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	64.4B
Avg	63.2B
Low	58.5B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	9.6%
Avg	7.6%
Low	-0.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	10.53
Avg	10.22
Low	9.64

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	15.0%
Avg	11.6%
Low	5.2%